Your industry needs you for the PM Society Diversity, Equity, and Inclusion Interest Group benchmarking survey 2024.

ViVE always offers an excellent opportunity to register the pulse of the digital healthcare industry and learn from the ...

To plug that gap, Germany’s Bayer has joined forces with electronics group Samsung to carry out an observational study on ...

The China-US trade war has spread to the biotech industry, as the US BIOSECURE Act looks to dampen Chinese influence on a ...

Just a few weeks after Dexcom’s Stelo became the first over-the-counter continuous glucose monitor (CGM) to be approved by ...

New data from a phase 2b trial of Moderna and MSD’s neoantigen melanoma vaccine may be strong enough to consider filing for ...

Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of ...

GSK is increasingly confident that its anti-BCMA drug Blenrep could be returned to the US market, after revealing data from ...

Finally, for its ASCO ‘Super Sunday’ hat trick, AZ and Daiichi Sankyo reported results from the DESTINY-Breast06 trial, which ...

Gilead Sciences’ bid to extend the uses of TROP2-directed Trodelvy into lung cancer currently rests on the results of its ...

At the ASCO congress in Chicago today, the results of the ASC4FIRST trial of Scemblix (asciminib) in people recently ...

Novartis’ anti-IgE antibody Xolair (omalizumab) has been a mainstay of treatment for refractory CSU for many years. However, ...